(Q40305502)

English

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines

scientific article published on 8 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

gastrointestinal stromal tumor

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maria Debiec-Rychter

4

object named as

Maria Debiec-Rychter

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Patrick Schöffski

6

object named as

Patrick Schoffski

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Hans Prenen

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gunther Guetens

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gert de Boeck

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Paul Manley

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Allan T van Oosterom

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ernst de Bruijn

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

8 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

11-16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib

1 reference

https://api.crossref.org/works/10.1159%2F000091943

21 January 2018

Identifiers

10.1159/000091943

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40305502&oldid=1894224629"